An at-home FIT test is a screening tool that may detect colon cancer. It works by testing for blood in the stool, which can be an early sign of colon cancer caused by colorectal polyps that leak blood ...

A large trial in US community health centers shows mailed FIT-DNA kits outperform FIT in boosting colorectal cancer screening. Despite this, fewer than 4 in 10 patients with abnormal results complete ...

When David Thau, a lobbyist in Washington, D.C., was 34, he periodically experienced pain in his stomach, irregular bowel movements, blood in his stool and vomiting, and he visited doctors who ...

Stool-based testing has poor sensitivity and low negative predictive value for colorectal cancer screening in patients with cystic fibrosis.

An 18% higher screening rates was seen among Hispanic, Black, and White patient populations with mailed fecal immunochemical testing. HealthDay News — Mailed fecal immunochemical tests (FITs) can ...

As of July 1, Ontarians age 45 and up are eligible to receive the at-home fecal immunochemical screening test — or FIT — that ...

Background: Racially and ethnically minoritized patients are underscreened for colorectal cancer, resulting in racial/ethnic disparities. This study examined an intervention consisting of a mailed ...

A pragmatic cluster-randomized trial across 8 CHC sites (Boston and Los Angeles) enrolled 5127 adults aged 45–75 years overdue for screening, randomizing clinics to FIT versus FIT-DNA outreach.

Patients received either mailed FIT with automated text message outreach from study personnel or mailed FIT-DNA with the manufacturer's outreach protocol. HealthDay News — Colorectal cancer (CRC) ...